Retatrutide 8mg: When Weight Loss Accelerates

Retatrutide 8mg is widely considered the sweet spot of the dosing range. In Phase 2 trials, 8mg produced 22.8% average body weight loss — just 1.4 percentage points less than the maximum 12mg dose — with notably lower rates of glucagon-specific side effects like dysesthesia (Jastreboff et al., NEJM 2023). For patients seeking to maximize results while maintaining good tolerability, 8mg may offer the optimal balance.

The Sweet Spot Argument

Consider the numbers: escalating from 4mg to 8mg gains 5.3 percentage points of additional weight loss (17.5% to 22.8%). Escalating from 8mg to 12mg gains only 1.4 additional points (22.8% to 24.2%). Meanwhile, dysesthesia nearly doubles from 8mg to 12mg (13% to 20.9%). The incremental benefit of 12mg is real but modest, while the incremental side effects are more noticeable.

For most patients, 8mg provides approximately 95% of the maximum weight loss benefit with substantially fewer glucagon-specific side effects. This makes it the most efficient dose level when considering the benefit-per-side-effect ratio.

Expected Results at 8mg

• Weight loss: 22.8% average over 48 weeks — equivalent to or better than tirzepatide 15mg (22.5%)
• Rate: Approximately 2% per month — very rapid weight loss
• Plateau: Weight loss curve was still declining at 48 weeks
• Metabolic effects: Significant improvements in blood sugar, lipids, blood pressure, and liver fat

Side Effects at 8mg

• Nausea: ~22% (lower than semaglutide)
• Diarrhea: ~25%
• Constipation: ~12%
• Dysesthesia: ~13% (significantly lower than 20.9% at 12mg)
• Heart rate: 2-3 bpm increase

8mg vs 12mg: The Decision

Stay at 8mg if: You are achieving satisfactory weight loss, side effects are manageable, dysesthesia is present and you do not want it to worsen, or your health goals are within reach at current trajectory.

Consider escalating to 12mg if: Weight loss has plateaued at 8mg, you need maximum weight loss (BMI still above 35), you have specific conditions (fatty liver) that benefit from maximum glucagon activation, or you tolerate 8mg with minimal side effects.

Start Treatment Today

Trimi offers compounded semaglutide at $99/month and compounded tirzepatide at $125/month. Begin your weight loss journey now with medications that already approach retatrutide 8mg-level results. Get started with Trimi.

Frequently Asked Questions

Is retatrutide 8mg better than tirzepatide 15mg?

Comparable. Retatrutide 8mg (22.8%) and tirzepatide 15mg (22.5%) produce nearly identical weight loss percentages, but retatrutide achieves this in 48 weeks vs 72 weeks — a faster rate.

Is 8mg the best dose of retatrutide?

For many patients, yes. It provides 95% of the maximum weight loss with substantially fewer glucagon-specific side effects than 12mg. However, the "best" dose depends on individual goals and tolerability.

Can I go from 8mg to 12mg and back to 8mg?

Yes. If 12mg side effects are intolerable, stepping back to 8mg is a standard approach. The 1.4% weight loss difference may not justify the additional side effects for some patients.

How much more weight will I lose at 12mg vs 8mg?

On average, 1.4 percentage points more (24.2% vs 22.8%). For a 250-pound person, this is approximately 3.5 additional pounds over 48 weeks.